Last reviewed · How we verify
NCT03274648
Dietary Interventions and Butyrate Production in Behçet's Patients
NA trial testing Oral butyrate in Behcet Syndrome in 17 participants. Completed in 5 July 2019.
1 May 2019
Quick facts
| Lead sponsor | Azienda Ospedaliero-Universitaria Careggi |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 17 |
| Start date | 27 September 2017 |
| Primary completion | 1 May 2019 |
| Estimated completion | 5 July 2019 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Oral butyrate
- Vegetarian diet
- Habitual diet
Conditions studied
- Behcet Syndrome — all drugs for Behcet Syndrome →
Sponsor
Azienda Ospedaliero-Universitaria Careggi — full company profile →
Who can join
Adults 18 to 70, any sex, with Behcet Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A dietary intervention trial will be performed on patients affected by Behçet's syndrome. Three different diets will be compared, analyzing their effects on the gut microbiota composition, on endogenous butyrate production and on the general symptoms in Behçet's patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03274648
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Behcet Syndrome
Currently open trials in the same condition.
- NCT06780462 — Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep V · Phase 3 · recruiting
- NCT06730958 — Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity · recruiting
- NCT06729112 — Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease Activity · recruiting
- NCT05200715 — AutoInflammatory Disease Alliance Registry (AIDA) · recruiting
Other Azienda Ospedaliero-Universitaria Careggi trials
Trials by the same sponsor.
- NCT07296055 — Endobronchial Valve in Tubercular and NTM Pulmonary Cavities. · NA · not yet recruiting
- NCT07289581 — Effect of Treatment With Butyric Acid in Anorexia Nervosa · NA · active not recruiting
- NCT06978608 — Ultrasound and Somatosensory Median Nerve Evaluation in CRPS I · not yet recruiting
- NCT07005882 — Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Ra · Phase 2 · not yet recruiting
- NCT06529601 — Comparison Between CAD/CAM and Conventional Mandibular Fixed Retainers. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03274648 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria Careggi
- Last refreshed: 28 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03274648.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing